Black Diamond Therapeutics, Inc.

NasdaqGS:BDTX Stock Report

Market Cap: US$268.9m

Black Diamond Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:BDTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
09 May 24BuyUS$5,467,744RA Capital Management, L.P.Company782,726US$7.43
17 Oct 23BuyUS$934,080Bellevue Asset Management AGCompany400,000US$2.34
05 Jul 23BuyUS$5,000,000New Enterprise Associates, Inc.Company1,000,000US$5.00
05 Jul 23BuyUS$4,679,250RA Capital Management, L.P.Company935,850US$5.00
30 Jun 23BuyUS$5,000,000Bellevue Asset Management AGCompany1,000,000US$5.00
27 Jun 23BuyUS$9,555,036Bellevue Asset Management AGCompany1,740,000US$5.49

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BDTX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies66,0700.117%
Individual Insiders1,292,4302.3%
General Public9,856,69317.5%
VC/PE Firms10,877,32119.3%
Institutions34,160,28060.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 54.1%.


Top Shareholders

Top 25 shareholders own 75.65% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.1%
Bellevue Asset Management AG
8,517,839US$40.7m-0.21%0.47%
12%
T. Rowe Price Group, Inc.
6,725,365US$32.1m71.2%no data
11.4%
Versant Venture Management, LLC
6,428,564US$30.7m0%10.38%
7.91%
New Enterprise Associates, Inc.
4,448,757US$21.3m0%1.37%
4.93%
RA Capital Management, L.P.
2,773,028US$13.3m-21.4%0.18%
3.39%
The Vanguard Group, Inc.
1,905,300US$9.1m-2.15%no data
2.85%
Tang Capital Management, LLC
1,603,200US$7.7m-11.1%0.89%
2.45%
BlackRock, Inc.
1,380,522US$6.6m2.26%no data
1.86%
Artal Group S.A.
1,046,517US$5.0m-48.9%0.11%
1.62%
David M. Epstein
913,479US$4.4m-2.47%no data
1.56%
Laurion Capital Management LP
878,286US$4.2m0%0.13%
1.27%
Kennedy Capital Management LLC
717,183US$3.4m-3.2%0.07%
1.24%
CHI Advisors LLC
695,000US$3.3m0%1.15%
1.08%
Driehaus Capital Management LLC
605,901US$2.9m-13.1%0.02%
0.97%
Millennium Management LLC
546,237US$2.6m348%no data
0.9%
Tavistock Life Sciences
506,000US$2.4m0%0.13%
0.75%
Susquehanna International Group, LLP, Asset Management Arm
423,923US$2.0m92.4%no data
0.68%
Geode Capital Management, LLC
382,613US$1.8m9.18%no data
0.64%
Two Sigma Investments, LP
358,064US$1.7m-2.51%no data
0.59%
Goldman Sachs Group, Investment Banking and Securities Investments
333,248US$1.6m625%no data
0.58%
Verition Fund Management LLC
328,906US$1.6m-78.8%0.02%
0.56%
Connor, Clark & Lunn Investment Management Ltd.
314,502US$1.5m0%0.01%
0.46%
UBS O'Connor LLC
257,000US$1.2m0%0.11%
0.45%
Jane Street Group, LLC, Asset Management Arm
250,555US$1.2m353%no data
0.38%
Renaissance Technologies LLC
212,600US$1.0m-52.8%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.